![Erich Bam](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erich Bam
Direttore operativo presso ViRexx Medical Corp.
Posizioni attive di Erich Bam
Società | Posizione | Inizio | Fine |
---|---|---|---|
ViRexx Medical Corp.
![]() ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Direttore operativo | 12/10/2007 | - |
Storia della carriera di Erich Bam
Formazione di Erich Bam
University of Stellenbosch | Undergraduate Degree |
University of South Africa | Graduate Degree |
Statistiche
Distribuzione geografica
Sud Africa | 3 |
Canada | 2 |
Posizioni
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Settori
Consumer Services | 3 |
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
ViRexx Medical Corp.
![]() ViRexx Medical Corp. Pharmaceuticals: MajorHealth Technology ViRexx Medical Corp. engages in the research, development, and commercialization of biopharmaceutical products for the treatment of cancer and chronic viral infections. It provides drugs for the treatment of ovarian cancer, chronic hepatitis B, hepatitis C and selected solid tumors. It has three platform technologies: The Antiboby-based immunotherapy and Chimigen platforms are designed to educate the immune system to recognize and remove cancer and chronic viruses in the body. The Targeted-Autothrombogenic cancer therapy platform is designed to cut off the blood supply to tumors, which leads to tumor tissue starvation and death. The company is headquartered in Edmonton, Canada. | Health Technology |
- Borsa valori
- Insiders
- Erich Bam
- Esperienza